Literature DB >> 11920640

Different pattern of loss of heterozygosity among endocervical-type adenocarcinoma, endometrioid-type adenocarcinoma and adenoma malignum of the uterine cervix.

Hitoshi Tsuda1, Teruko Takarabe, Satoshi Okada, Hiroshi Uchida, Takahiro Kasamatsu, Takuro Yamada, Ryuichiro Tsunematsu, Kazuo Ohmi, Setsuo Hirohashi.   

Abstract

It is unclear which chromosome arms frequently show loss of heterozygosity (LOH) in adenocarcinoma of the uterine cervix. To identify such chromosomal arms, LOH on 52 different chromosome loci was examined using laser capture microdissection and PCR-LOH analysis in 25 common-type adenocarcinomas, comprising 13 cases of endocervical type, 12 cases of endometrioid type and 7 cases of adenoma malignum without the component of conventional endocervical-type adenocarcinoma (designated as "pure" form). In adenocarcinomas of endocervical type and endometrioid type, LOH was commonly detected on chromosome arms 17p (62% and 50%, respectively), 1p (33% and 67%) and 22q (40% and 33%). In addition, endocervical-type adenocarcinoma frequently (> or = 30%) showed LOH on 18p (71%), 19q (50%), 19p (38%) and 16q (38%), whereas endometrioid-type adenocarcinoma frequently showed LOH on 10q (43%) and 5q (40%). LOH was only sporadically detected on 9q, 18q, or 21q in 3 of 7 cases of "pure" adenoma malignum. In a case of coexistence of "pure" adenoma malignum and adenocarcinoma in situ (AIS), LOH on 1q, 5p, 11p, 17p, 18p and 18q was detected only in AIS. LOH was accumulated on a number of chromosome arms in the adenocarcinoma at the early developmental stage before stromal invasion. Chromosomal arms that are prone to show LOH appeared to differ between the 2 types of cervical adenocarcinoma. We could suggest that "pure" adenoma malignum is of clonal and neoplastic nature in view of the detection of LOH. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11920640     DOI: 10.1002/ijc.10228

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  4 in total

1.  Well-differentiated mucinous uterine adenocarcinoma predominantly diagnosed as adenoma malignum: a case report with an immunohistochemical analysis.

Authors:  Andrzej Semczuk; Jacek Tomaszewski; Marek Gogacz; Bogdan Obrzut; Marina Rigau; Dorota Lewkowicz; Anna Semczuk-Sikora
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

2.  Impairment of MLH1 and CDKN2A in oncogenesis of laryngeal cancer.

Authors:  M M Sasiadek; A Stembalska-Kozlowska; R Smigiel; D Ramsey; T Kayademir; N Blin
Journal:  Br J Cancer       Date:  2004-04-19       Impact factor: 7.640

3.  Coordinate H3K9 and DNA methylation silencing of ZNFs in toxicant-induced malignant transformation.

Authors:  Paul L Severson; Erik J Tokar; Lukas Vrba; Michael P Waalkes; Bernard W Futscher
Journal:  Epigenetics       Date:  2013-08-06       Impact factor: 4.528

4.  19q13 KRAB zinc-finger protein ZNF471 activates MAPK10/JNK3 signaling but is frequently silenced by promoter CpG methylation in esophageal cancer.

Authors:  Ran Sun; Tingxiu Xiang; Jun Tang; Weiyan Peng; Jie Luo; Lili Li; Zhu Qiu; Yiqing Tan; Lin Ye; Min Zhang; Guosheng Ren; Qian Tao
Journal:  Theranostics       Date:  2020-01-12       Impact factor: 11.556

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.